What's the The McCairn Protocol for Covd Related Injuries?
The McCairn Protocol (EdogawaโMcCairn Protocol): Overview and Mechanistic Rationale
The McCairn Protocol (also referred to as the EdogawaโMcCairn Protocol) is an experimental, two-phase treatment approach promoted by Kevin McCairn in collaboration with Edogawa Hospital.
It is primarily proposed for individuals with Long COVID and post-mRNA vaccineโassociated syndromes, targeting hypothesized drivers such as persistent spike protein, amyloid-like fibrin microclots, autoantibodies, chronic inflammation, and associated vascular or neurological dysfunction.
The Long COVID Crisis: Why Patients Are Desperate for Answers
Long COVID has become one of the most pressing public health challenges of the 2020s. Millions of people worldwide continue to suffer from debilitating symptoms months or years after their initial infectionโfatigue, brain fog, shortness of breath, heart palpitations, muscle pain, and dysautonomia. For many, conventional medicine has offered little relief, with treatments largely limited to symptom management and rehabilitation.
Itโs no surprise that patients are turning to experimental protocols, seeking a definitive cure. Enter the McCairnโEdogawa Protocol, a controversial and unorthodox treatment regimen that has gained traction in online communities, particularly among those who feel abandoned by mainstream healthcare.
But does it work?ย
What Is the McCairnโEdogawa Protocol?
The McCairn Protocol, developed by Kevin McCairn in collaboration with Tokyoโs Edogawa Hospital, is a two-phase treatment plan designed to address what its proponents believe are the root causes of Long COVID and post-vaccine syndromes.
Phase 1: Anticoagulation and Microclot Removal
The first phase focuses on dissolving amyloid-like fibrin microclotsโtiny, sticky blood clots that have been detected in the blood of Long COVID patients. These microclots are believed to block capillaries, impair oxygen delivery, and trigger inflammation. The protocol uses a combination of anticoagulant medications, often including low-dose nattokinase (an enzyme from natto) and other fibrinolytic agents, to break down these clots.
Phase 2: Spike Protein Clearance and Immune Modulation
The second phase aims to clear persistent spike proteinโeither from the virus itself or from mRNA vaccinesโwhich some researchers believe continues to circulate and cause inflammation long after the initial event. This phase may involve treatments such as ivermectin, statins (to reduce endothelial inflammation), and other agents thought to bind to or eliminate spike protein. Additionally, immune-modulating drugs are used to address autoantibodies and calm the chronic inflammatory response.
The protocol also includes aggressive supplementation with vitamins, minerals, and antioxidants, along with strict dietary modifications.
The Evidence: What Science Actually Says
Microclots: A Legitimate Finding
The presence of microclots in Long COVID patients is one of the most robust findings in the emerging research. Studies published in Blood, The Lancet, and Nature have confirmed that many Long COVID patients have persistent fibrin microclots that resist normal breakdown. This has led to small clinical trials evaluating nattokinase, heparin, and other anticoagulants.ย ย
Anecdotal reports online from various people that have undergone the treatment, claim 90% recovery, such as Lyndsey, RN on X.com: @HouseLyndseyRN
Spike Protein Persistence: Controversial but Plausible
The idea that spike protein lingers in the body months after infection or vaccination is not controversial. Some studies have detected spike protein in the blood of Long COVID patients, while others have not. If it does persist, it may contribute to ongoing inflammation via the ACE2 receptor and immune activation.ย ย
The Appeal: Why Patients Are Flocking to Japan
Edogawa Hospital in Tokyo has become a destination for medical tourism among Long COVID patients. The protocol is heavily promoted in online forums, Telegram groups, and YouTube testimonials. Patients report dramatic improvementsโcomplete resolution of brain fog, fatigue, and shortness of breath after just weeks of treatment.
The emotional appeal is undeniable. When conventional medicine tells you there is no cure, and someone offers a structured protocol with dramatic success stories, it's easy to believe.
But testimonials are not data. Without a control group, itโs impossible to know how many patients improved spontaneously, how many got worse, or how many experienced adverse effects from the aggressive anticoagulation therapy.
The Risks: What Could Go Wrong?
Anticoagulants, even at low doses, carry real risks, including internal bleeding, hemorrhagic stroke, and drug interactions. Nattokinase, though generally safe as a supplement, is not FDA-approved for therapeutic use. Patients taking prescription blood thinners or with bleeding disorders could face serious complications.
Furthermore, the protocol often requires patients to travel to Japan, incur significant costs, and discontinue other treatments. For some, this may mean abandoning supportive therapies that were providing at least partial benefit.
A Skeptical View: Placebo, Natural Recovery, or Real Effect?
It is well established that Long COVID symptoms fluctuate and often improve over time. The natural history of the condition is not fully understood, and many patients experience spontaneous remission. The intense placebo effect of traveling abroad, receiving a structured protocol from a charismatic advocate, and being surrounded by a community of believers cannot be underestimated.
Until rigorous clinical trials are conducted, it is impossible to separate the protocol's specific effects from the natural course of the disease, regression to the mean, or the powerful psychological impact of hope itself.
The Broader Context: Desperate Times, Desperate Measures
The McCairnโEdogawa Protocol is yet another chapter in the long history of alternative medicine targeting desperate patient populations. Like the Gerson therapy for cancer or the autismโbleach "cure," it offers a simple, mechanistic explanation for a complex syndrome and promises a definitive solution.
The pattern is familiar: A charismatic figure emerges, partners with a hospital or clinic, publishes a protocol, and shares dramatic testimonials. Mainstream medicine is slow to respond, leaving a vacuum that alternative treatments fill. Patients who recoverโfor any reasonโbecome evangelists. Those who don't recover often remain silent.
What Should Patients Do?
If you are suffering from Long COVID and considering the McCairn Protocol, consider the following:
- Talk to your doctor. Discuss the risks of anticoagulation and any potential interactions with your current medications.
- Look for clinical trials. Several legitimate studies are underway evaluating nattokinase, anticoagulants, and immunomodulators for Long COVID. Participation in a trial may give you access to cutting-edge treatments with proper safety monitoring.
- Be skeptical of any protocol that requires international travel and significant out-of-pocket costs. Real medical breakthroughs do not require you to fly to a foreign country to receive them.
- Do not abandon proven therapies. Low-dose naltrexone, graded exercise therapy, cognitive rehabilitation, and autonomic nervous system support have all shown benefit in Long COVID and are widely available.
- Watch for red flags. Claims of "100% recovery," "cure," or "they don't want you to know this" are signs of marketing, not medicine.
Conclusion: Hope, YesโBut Let Evidence Lead
The McCairnโEdogawa Protocol addresses legitimate biological mechanismsโmicroclots and persistent spike proteinโthat may play a role in Long COVID. In that sense, it is more scientifically grounded than many alternative treatments. But the evidence for its safety and efficacy remains preliminary at best.
Long COVID patients have been failed by a medical system that is only beginning to take their condition seriously. That failure creates fertile ground for experimental protocols, some of which may eventually prove useful.
